F4 - The Role of Opioid Treatment Programs in Implementing the National Drug Control Strategy

Thursday, November 3, 2022

10:00 AM – 11:30 AM

Location: Peale A-C, Level 1

CE: 1.5

Primary Presenter(s)

Robert A. Kent, JD

General Counsel
White House Office of National Drug Control Policy
Washington, District of Columbia

Co-Presenter(s)

Elizabeth Connolly, MPA

Assistant Director, Public Health
Office of National Drug Control Policy
Washington, District of Columbia

Download Slides

Learning Objectives:

At the completion of this activity, participants will:

Describe the federal priorities for the overdose epidemic and how OTPs fit within those priorities.
Explain the role of ONDCP in coordinating federal drug control funding and drug policy.
Assess the role played by OTPs with implementing the National Drug Control Strategy.

Presentation Summary: This workshop will provide insights for the participants regarding the role of the White House Office of National Drug Control Policy in coordinating drug policy for the federal government. The presentation will also discuss the 2022 National Drug Control Policy and the role of Opioid Treatment Programs with implementing it.